Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
M. Kar, K. E. E. Johnson, A. Vanderheiden, E. J. Elrod, K. Floyd, E. Geerling, E. T. Stone, E. Salinas, S. Banakis, W. Wang, S. Sathish, S. Shrihari, M. E. Davis-Gardner, J. Kohlmeier, A. Pinto, , M. S. Suthar
This study shows that CD4+ and CD8+ T cells are necessary to prevent SARS-CoV-2 persistence in the nasal compartment but not in the lungs.
bioRxiv · Jan 23, 2024Immunology
L. Cervantes-Barragan, A. Vanderheiden, C. J. Royer, M. E. Davis-Gardner, P. Ralfs, T. Chirkova, L. J. Anderson, A. Grakoui, M. S. Suthar
This study shows that plasmacytoid dendritic cells recognize SARS-CoV-2, produce type I and III interferons, and reduce viral replication in infected airway epithelial cells.
bioRxiv · May 12, 2021 · PreprintImmunology
A. Vanderheiden, J. Thomas, A. L. Soung, M. E. Davis-Gardner, K. Floyd, F. Jin, D. A. Cowan, K. Pellegrini, A. Creanga, A. Pegu, A. Derrien-Colemyn, P.-Y. Shi, A. Grakoui, R. S. Klein, S. E. Bosinger, , M. S. Suthar
This study identifies a CCR2-dependent monocyte-derived cell mechanism that restricts SARS-CoV-2 infection and inflammation in the lungs of mice.
bioRxiv · May 3, 2021 · PreprintImmunology
M. Jennewein, A. MacCamey, N. Akins, J. Feng, L. Homad, N. Hurlburt, E. Seydoux, Y.-H. Wang, A. B. Stuart, V. V. Edara, K. Floyd, A. Vanderheiden, J. R. Mascola, N. Doria-Rose, L. Wang, , L. Stamatatos
The paper isolates and characterizes cross-neutralizing antibodies from COVID-19 patients, identifying antibodies that neutralize both SARS-CoV-1 and SARS-CoV-2, including variants.
bioRxiv · Mar 23, 2021 · PreprintImmunology
B. A. Johnson, X. Xie, B. Kalveram, K. G. Lokugamage, A. Muruato, J. Zou, X. Zhang, T. Juelich, J. K. Smith, L. Zhang, C. Schindewolf, M. N. Vu, A. Vanderheiden, J. A. Plante, K. S. Plante, , V. D. Menachery
This study shows that removing the furin cleavage site from SARS-CoV-2 increases replication in Vero cells but reduces replication in respiratory cells and pathogenesis in hamsters, while also decreasing neutralization susceptibility.
bioRxiv · Aug 26, 2020 · PreprintMicrobiology
A. Vanderheiden, P. Ralfs, T. Chirkova, A. A. Upadhyay, M. G. Zimmerman, S. Bedoya, H. Aoued, G. K. Tharp, K. Pellegrini, A. C. Lowen, V. D. Menachery, L. J. Anderson, A. Grakoui, S. E. Bosinger, M. S. Suthar
This study shows SARS-CoV-2 infects human airway epithelial cultures, induces pro-inflammatory cytokines, and is inhibited by type I and III IFNs.
bioRxiv · May 19, 2020Microbiology